INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
03 · Corporate insiders

Form 4 filings

Officers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.

Form 4 transactions

Cluster activity · 60d

Most active filers

Companies with the most Form 4 filings
Data sources
SEC Form 42h ago
House PTR2h ago
SEC 13F2h ago
Robinhood Chain2h ago

Most active filers · 30d

  1. 01Kurtz George0B / 215S215 trades$52.62M
  2. 02FWFogarty Patrick W0B / 150S150 trades$600K
  3. 03SPSaba Capital Management, L.P.65B / 19S · 11 late84 trades$21.64M
  4. 04ATAdair Kathleen Theresa52B / 0S · 52 late52 trades$18K
  5. 05AJAllaire Jeremy0B / 50S50 trades$4.26M
  6. 06Wilhelmsen Arne Alexander0B / 47S47 trades$241.96M
  7. 07SJSheena Jonathan0B / 45S45 trades$3.01M
  8. 08SISarowitz Steven I2B / 34S36 trades$22.46M
  9. 09SLSpeiser Michael L0B / 35S35 trades$14.00M
  10. 10RARothblatt Martine A0B / 33S33 trades$5.50M

Cluster activity · 60d

  1. BUYTSMTAIWAN SEMICONDUCTOR MANUFACTURING CO LTDNov 5 – Nov 1732 insiders$917K
  2. SELLDRDDRDGOLD LTDOct 27 – Oct 2710 insiders$1.23M
  3. BUYMTDRMatador Resources CoNov 5 – Nov 109 insiders$765K
  4. SELLMSIMotorola Solutions, Inc.Nov 6 – Nov 168 insiders$42.58M
  5. SELLFFIVF5, INC.Nov 3 – Nov 58 insiders$8.37M
  6. SELLIBEXIBEX LtdNov 9 – Nov 167 insiders$3.36M
  7. SELLMGNIMAGNITE, INC.Nov 5 – Nov 127 insiders$2.27M
  8. SELLSYMSymbotic Inc.Oct 26 – Nov 27 insiders$1.98M

Form 4 transactions

72,525 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
Include
grants & admin
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
3
BM
Benkowitz MichaelPRESIDENT AND COO
UTHRUNITED THERAPEUTICS Corp
Option exercise · 10b5-1 plan
M—
14.6K sh
Jan 12, 2026Jan 13, 2026
Page 1496 of 1814
← PrevNext →
traded Jan 12, 2026
+1d
SEC Form 4

Evidence

3
RM
Rodman David MalcomChief Medical Officer
MLYSMineralys Therapeutics, Inc.
Option exercise · 10b5-1 plan
M—
2,170 sh
Jan 9, 2026Jan 13, 2026
traded Jan 9, 2026
+4dSEC Form 4

Evidence

3
BM
Benkowitz MichaelPRESIDENT AND COO
UTHRUNITED THERAPEUTICS Corp
Option exercise · 10b5-1 plan
M—
7,875 sh
Jan 12, 2026Jan 13, 2026
traded Jan 12, 2026
+1dSEC Form 4

Evidence

3
CM
Cannon-Brookes MichaelDirector, CEO, Co-Founder, 10% Owner
TEAMAtlassian Corp
Open-market sale · 10b5-1 plan
SELL$25K
170 sh
Jan 12, 2026Jan 13, 2026
traded Jan 12, 2026
+1dSEC Form 4

Evidence

1
WL
Wu LeiDirector, Chief Executive Officer, 10% Owner
GCTGigaCloud Technology Inc
Open-market sale · 10b5-1 plan
SELL$82K
2,010 sh
Jan 13, 2026Jan 13, 2026
traded Jan 13, 2026
+0dSEC Form 4

Evidence

1
RM
Rizik MatthewDirector
RKTRocket Companies, Inc.
Open-market sale · 10b5-1 plan
SELL$57K
2,500 sh
Jan 9, 2026Jan 13, 2026
traded Jan 9, 2026
+4dSEC Form 4

Evidence

1
WL
Wu LeiDirector, Chief Executive Officer, 10% Owner
GCTGigaCloud Technology Inc
Open-market sale · 10b5-1 plan
SELL$173K
4,100 sh
Jan 12, 2026Jan 13, 2026
traded Jan 12, 2026
+1dSEC Form 4

Evidence

1
RM
Rizik MatthewDirector
RKTRocket Companies, Inc.
Open-market sale · 10b5-1 plan
SELL$57K
2,500 sh
Jan 12, 2026Jan 13, 2026
traded Jan 12, 2026
+1dSEC Form 4

Evidence

0
HA
Houston AndrewDirector, Chief Executive Officer, 10% Owner
DBXDROPBOX, INC.
Derivative conversion · 10b5-1 plan
C—
36.2K sh
Jan 9, 2026Jan 13, 2026
traded Jan 9, 2026
+4dSEC Form 4

Evidence

0
HA
Houston AndrewDirector, Chief Executive Officer, 10% Owner
DBXDROPBOX, INC.
Derivative conversion · 10b5-1 plan
C—
23.8K sh
Jan 12, 2026Jan 13, 2026
traded Jan 12, 2026
+1dSEC Form 4

Evidence

0
AK
Ahn KennethPresident, Hagerty Marketplace
HGTYHagerty, Inc.
Derivative conversion · 10b5-1 plan
C—
50.0K sh
Jan 12, 2026Jan 13, 2026
traded Jan 12, 2026
+1dSEC Form 4

Evidence

0
HA
Houston AndrewDirector, Chief Executive Officer, 10% Owner
DBXDROPBOX, INC.
Derivative conversion · 10b5-1 plan
C—
36.2K sh
Jan 9, 2026Jan 13, 2026
traded Jan 9, 2026
+4dSEC Form 4

Evidence

0
WL
Wu LeiDirector, Chief Executive Officer, 10% Owner
GCTGigaCloud Technology Inc
Open-market sale · 10b5-1 plan
SELL$22K
510 sh
Jan 13, 2026Jan 13, 2026
traded Jan 13, 2026
+0dSEC Form 4

Evidence

0
RM
Rodman David MalcomChief Medical Officer
MLYSMineralys Therapeutics, Inc.
Option exercise · 10b5-1 plan
M$6,856
6,348 sh
Jan 12, 2026Jan 13, 2026
traded Jan 12, 2026
+1dSEC Form 4

Evidence

0
RM
Rodman David MalcomChief Medical Officer
MLYSMineralys Therapeutics, Inc.
Option exercise · 10b5-1 plan
M—
6,348 sh
Jan 12, 2026Jan 13, 2026
traded Jan 12, 2026
+1dSEC Form 4

Evidence

0
TR
Taub RebeccaDirector
MDGLMADRIGAL PHARMACEUTICALS, INC.
Option exercise · 10b5-1 plan
M$3,792
240 sh
Jan 9, 2026Jan 13, 2026
traded Jan 9, 2026
+4dSEC Form 4

Evidence

0
AK
Ahn KennethPresident, Hagerty Marketplace
HGTYHagerty, Inc.
Derivative conversion · 10b5-1 plan
C—
1,350 sh
Jan 9, 2026Jan 13, 2026
traded Jan 9, 2026
+4dSEC Form 4

Evidence

0
AK
Ahn KennethPresident, Hagerty Marketplace
HGTYHagerty, Inc.
Derivative conversion · 10b5-1 plan
C—
1,350 sh
Jan 9, 2026Jan 13, 2026
traded Jan 9, 2026
+4dSEC Form 4

Evidence

0
FA
Friedman Paul ADirector
MDGLMADRIGAL PHARMACEUTICALS, INC.
Option exercise · 10b5-1 plan
M—
24.5K sh
Jan 9, 2026Jan 13, 2026
traded Jan 9, 2026
+4dSEC Form 4

Evidence

0
FA
Friedman Paul ADirector
MDGLMADRIGAL PHARMACEUTICALS, INC.
Option exercise · 10b5-1 plan
M$4,424
280 sh
Jan 9, 2026Jan 13, 2026
traded Jan 9, 2026
+4dSEC Form 4

Evidence

0
FA
Friedman Paul ADirector
MDGLMADRIGAL PHARMACEUTICALS, INC.
Option exercise · 10b5-1 plan
M—
280 sh
Jan 9, 2026Jan 13, 2026
traded Jan 9, 2026
+4dSEC Form 4

Evidence

0
BR
Britt Christopher RDirector, Chief Executive Officer
CHYMChime Financial, Inc.
Derivative conversion · 10b5-1 plan
C—
50.0K sh
Jan 9, 2026Jan 13, 2026
traded Jan 9, 2026
+4dSEC Form 4

Evidence

0
AK
Ahn KennethPresident, Hagerty Marketplace
HGTYHagerty, Inc.
Derivative conversion · 10b5-1 plan
C—
50.0K sh
Jan 12, 2026Jan 13, 2026
traded Jan 12, 2026
+1dSEC Form 4

Evidence

0
WL
Wu LeiDirector, Chief Executive Officer, 10% Owner
GCTGigaCloud Technology Inc
Open-market sale · 10b5-1 plan
SELL$29K
685 sh
Jan 13, 2026Jan 13, 2026
traded Jan 13, 2026
+0dSEC Form 4

Evidence

0
HA
Houston AndrewDirector, Chief Executive Officer, 10% Owner
DBXDROPBOX, INC.
Derivative conversion · 10b5-1 plan
C—
23.8K sh
Jan 12, 2026Jan 13, 2026
traded Jan 12, 2026
+1dSEC Form 4

Evidence

0
RM
Rodman David MalcomChief Medical Officer
MLYSMineralys Therapeutics, Inc.
Option exercise · 10b5-1 plan
M$35K
2,170 sh
Jan 9, 2026Jan 13, 2026
traded Jan 9, 2026
+4dSEC Form 4

Evidence

0
TR
Taub RebeccaDirector
MDGLMADRIGAL PHARMACEUTICALS, INC.
Option exercise · 10b5-1 plan
M—
240 sh
Jan 9, 2026Jan 13, 2026
traded Jan 9, 2026
+4dSEC Form 4

Evidence

0
HR
Howard Justyn RussellDirector, Executive Chair, 10% Owner
SPTSprout Social, Inc.
Derivative conversion · 10b5-1 plan
C—
40.0K sh
Jan 9, 2026Jan 13, 2026
traded Jan 9, 2026
+4dSEC Form 4

Evidence

0
TR
Taub RebeccaDirector
MDGLMADRIGAL PHARMACEUTICALS, INC.
Option exercise · 10b5-1 plan
M—
18.4K sh
Jan 9, 2026Jan 13, 2026
traded Jan 9, 2026
+4dSEC Form 4

Evidence

46
AE
Alvarez Divo Carlos EduardoDirector
EXFYExpensify, Inc.
Open-market sale
SELL$3,751
2,468 sh
Dec 30, 2025Jan 12, 2026
traded Dec 30, 2025
+13dSEC Form 4

Evidence

44
SS
Smith StanDirector
MAIAMAIA Biotechnology, Inc.
Open-market purchase
BUY$9,959
2,700 sh
Sep 19, 2022Jan 12, 2026
traded Sep 19, 2022
+1211dSEC Form 4

Evidence

43
DK
Dabrowski KonradChief AI & Growth Officer
LUCYInnovative Eyewear Inc
Open-market purchase
BUY$2,054
1,300 sh
Jan 8, 2026Jan 12, 2026
traded Jan 8, 2026
+4dSEC Form 4

Evidence

43
GR
Gross Harrison R.Director, Chief Executive Officer
LUCYInnovative Eyewear Inc
Open-market purchase
BUY$2,400
1,500 sh
Jan 8, 2026Jan 12, 2026
traded Jan 8, 2026
+4dSEC Form 4

Evidence

42
AE
Alvarez Divo Carlos EduardoDirector
EXFYExpensify, Inc.
Open-market sale
SELL$9,756
6,504 sh
Dec 31, 2025Jan 12, 2026
traded Dec 31, 2025
+12dSEC Form 4

Evidence

41
NB
Nelson BlakeCFO & Treasurer
NXGNXG NextGen Infrastructure Income Fund
Open-market purchase
BUY$17K
326 sh
Jan 8, 2026Jan 12, 2026
traded Jan 8, 2026
+4dSEC Form 4

Evidence

41
BR
Bousquet RaphaelChief Revenue Offucer
NTSKNetskope Inc
Open-market sale
SELL$55K
3,224 sh
Jan 8, 2026Jan 12, 2026
traded Jan 8, 2026
+4dSEC Form 4

Evidence

39
HA
Hui AnChief Operating Officer
LAKELAKELAND INDUSTRIES INC
Open-market purchase
BUY$18K
2,000 sh
Jan 9, 2026Jan 12, 2026
traded Jan 9, 2026
+3dSEC Form 4

Evidence

37
BR
Bousquet RaphaelChief Revenue Offucer
NTSKNetskope Inc
Open-market sale
SELL$52K
3,192 sh
Jan 9, 2026Jan 12, 2026
traded Jan 9, 2026
+3dSEC Form 4

Evidence

37
BR
Bousquet RaphaelChief Revenue Offucer
NTSKNetskope Inc
Open-market sale
SELL$64K
3,823 sh
Jan 12, 2026Jan 12, 2026
traded Jan 12, 2026
+0dSEC Form 4

Evidence

37
CW
Chou WilliamDirector, PRESIDENT AND CEO
PASGPassage BIO, Inc.
Open-market sale
SELL$75K
4,076 sh
Jan 8, 2026Jan 12, 2026
traded Jan 8, 2026
+4dSEC Form 4

Evidence